 patients with symptomatic disease before EVAR or
OSR.

Quality of evidence

A (High)

Level of recommendation

2 (Weak)

Quality of evidence

C (Low)

We recommend using FDA-approved branch endograft
devices in anatomically suitable patients to maintain
perfusion to at least one internal iliac artery.
Level of recommendation

1 (Strong)

Quality of evidence

A (High)

We recommend staging bilateral internal iliac artery occlusion
by at least 1 to